HNF4A and malignant colon neoplasm: To implement our novel screening approach, we have used primary colon cancer cells as proof of principle and have tested the hypothesis, derived from our previous work (Varnat et al, 2010), that at least some colon cancer metastatic suppressors should directly or indirectly enhance or support endogenous WNT-TCF signaling.